FundedIQ

Recently Funded Series C Biotechnology Startups

Updated Sep 2026

FundedIQ holds 183 funded Series C Biotechnology startups and keeps their funding rounds, amounts, investors, industries, locations and company details up to date. This page provides an overview of the Series C Biotechnology startup funding landscape, along with the 100 most recently funded Series C Biotechnology startups.

Series C Biotechnology startups closed 57 funding rounds over the last 24 months, 30 of them in the last 12 months, and raised $5.3B in disclosed capital. The median disclosed round is $80M, with the middle half of rounds falling between $36M and $115M. Cambridge and Boston hold the deepest concentrations of these companies.

Fidelity and Alpha Wave Global lead the funding mix, bringing institutional scale to these biotechnology ventures. Sanofi Ventures adds strategic pharmaceutical oversight. This mix of crossover funds and corporate venture capital indicates a shift toward late stage validation. Much of this activity clusters in Cambridge and Boston, reflecting a heavy reliance on established academic and research centers.

Series C Biotechnology funded startup statistics

Funded Series C Biotechnology startups
183
tracked in the database
Funding rounds, last 12 months
30
57 over 24 months
Disclosed capital raised, 24 months
$5.3B
55 of 57 rounds disclosed an amount
Median round size
$80M
middle half $36M to $115M

Most recent funding round on record: Sep 2026. Investors appearing most often across Biotechnology funding rounds: Fidelity, Alpha Wave Global, Sanofi Ventures.

100 most recently funded Series C Biotechnology startups

100 of 183

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

I
Columbia, United States · Biotechnology
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Series C ·
$10M
B
Northbrook, United States · Biotechnology
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
Series C ·
$110M
E
South San Francisco, United States · Biotechnology
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Series C ·
$90M
C
Burlington, United States · Biotechnology
CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to…
Series C ·
$37M
T
San Francisco, United States · Biotechnology
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has…
Series C ·
$9.0M
W
St Louis, United States · Biotechnology
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.The company's…
Series C ·
$35M
F
Cambridge, United States · Biotechnology
Flare Therapeutics is a biotech firm that is venturing into a new therapeutic domain by taking a unique…
Series C ·
$85M
T
Waltham, United States · Biotechnology
Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a…
Series C ·
$65M
C
Auburndale, United States · Biotechnology
CereVasc specializes in creating new, less invasive medical devices for treating patients with neurological…
Series C ·
$85M
N
South San Francisco, United States · Biotechnology
NewLimit is a biotechnology company dedicated to significantly increasing human healthspan. We are working on…
Series C ·
$435M
C
Boston, United States · Biotechnology
Cerevance is a biotech firm that creates new treatments for neurological disorders, specifically focusing on…
Series C ·
$20M
S
Cambridge, United Kingdom · Biotechnology
STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes…
Series C ·
$56M
T
San Francisco, United States · Biotechnology
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop…
Series C ·
$108M
A
Copenhagen, Denmark · Biotechnology
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
Series C ·
$75M
C
Cambridge, United States · Biotechnology
Cognito Therapeutics is a company that specializes in neurotechnology and is currently at the clinical stage.…
Series C ·
$105M
S
Alameda, United States · Biotechnology
Science is a new company that focuses on creating advanced technologies to address various urgent medical…
Series C ·
$230M
C
Dallas, United States · Biotechnology
Colossal creates disruptive technologies for extinct species restoration, critically endangered species…
Series C ·
$60M
A
Menlo Park, United States · Biotechnology
Antheia focuses on creating biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients…
Series C ·
$24M
N
Cambridge, United Kingdom · Biotechnology
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing…
Series C ·
$12M
B
Cambridge, United Kingdom · Biotechnology
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.…
Series C ·
$50M
U
Palo Alto, United States · Biotechnology
Ukko is a biotech firm focused on creating safe immunotherapies for quickly addressing allergies and other…
Series C ·
$45M
S
San Francisco, United States · Biotechnology
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious…
Series C ·
$200M
A
San Diego, United States · Biotechnology
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need,…
Series C ·
$115M
H
Copenhagen, Denmark · Biotechnology
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
Series C ·
$157M
T
Munich, Germany · Biotechnology
Tubulis creates specialized chemotherapy drugs that target cancer and chronic illnesses by combining unique…
Series C ·
$358M
O
Jerusalem, Israel · Biotechnology
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents…
Series C ·
$25M
A
Waltham, United States · Biotechnology
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV)…
Series C ·
$40M
L
Seattle, United States · Biotechnology
Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic…
Series C ·
$30M
K
Longmont, United States · Biotechnology
KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular…
Series C ·
$8.0M
K
Redwood City, United States · Biotechnology
Kriya is a next-generation gene therapy company focused on designing and developing transformative new…
Series C ·
$313M
G
New York, United States · Biotechnology
Gameto is a biotechnology company focused on revolutionizing women's reproductive health through the…
Series C ·
$44M
E
Lyon, France · Biotechnology
Established in January 2014, ENYO Pharma is a biopharmaceutical company founded by four scientists from the…
Series C ·
$6.9M
C
Cambridge, United Kingdom · Biotechnology
Inobrodib is a capsule taken orally and is the first small molecule drug in clinical trials that targets the…
Series C ·
$120M
A
San Carlos, United States · Biotechnology
Attovia develops biotherapeutics aimed at treating immune-mediated diseases through its proprietary ATTOBODY…
Series C ·
$90M
A
Durham, United States · Biotechnology
Atsena Therapeutics is a company in the advanced stages of testing genetic therapy that aims to reverse or…
Series C ·
$150M
C
New York, United States · Biotechnology
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical…
Series C ·
Undisclosed
A
Cambridge, United States · Biotechnology
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic…
Series C ·
$74M
E
Boulder, United States · Biotechnology
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Series C ·
$20M
A
Sydney, Australia · Biotechnology
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
Series C ·
$112M
U
Seattle, United States · Biotechnology
Umoja Biopharma specializes in cutting-edge immunotherapy that involves modifying T cells in the patient's…
Series C ·
$100M
A
Agoura Hills, United States · Biotechnology
A2 Biotherapeutics specializes in T cell therapies that accurately differentiate between solid tumors and…
Series C ·
$80M
N
Wadenswil, Switzerland · Biotechnology
Numab is a biotechnology company that provides antibody-based treatments for serious illnesses like chronic…
Series C ·
$55M
G
Saint Louis, United States · Biotechnology
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational…
Series C ·
$105M
A
Cambridge, United States · Biotechnology
Aviceda Therapeutics is a biotech company in the late stages of pre-clinical development that is focused on…
Series C ·
$208M
S
Bozeman, United States · Biotechnology
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They…
Series C ·
$100M
C
Konstanz, Germany · Biotechnology
CarboCode develops sphingolipids that are useful for the operation of the brain, skincare, and the…
Series C ·
$16M
C
Cortechs.ai
San Diego, United States · Biotechnology
Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists,…
Series C ·
Undisclosed
P
New York, United States · Biotechnology
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Series C ·
$93M
A
Vancouver, Canada · Biotechnology
Alpha-9 Theranostics is a clinical stage, radiopharmaceutical company developing differentiated and highly…
Series C ·
$175M
I
Schlieren, Switzerland · Biotechnology
ImmunOs Therapeutics AG is a clinical-stage biotechnology organization zeroed in on finding and creating…
Series C ·
$11M
A
South San Francisco, United States · Biotechnology
ArsenalBio, established in 2019, is dedicated to developing immune cell therapies that are both highly…
Series C ·
$325M
E
Boston, United States · Biotechnology
Elektrofi is a preclinical-stage organization devoted to reclassifying the norm of medication conveyance by…
Series C ·
$112M
M
Carmel, United States · Biotechnology
MBX Biosciences is a biotechnology company that specializes in creating therapies for rare endocrine…
Series C ·
$64M
S
Boston, United States · Biotechnology
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The…
Series C ·
$150M
F
San Francisco, United States · Biotechnology
Frontier Medicines is a biopharmaceutical company utilizing a chemoproteomics platform to expedite the…
Series C ·
$20M
A
San Diego, United States · Biotechnology
Aardvark Therapeutics, founded by Tien Lee in 2017, focuses on developing small molecule treatments for…
Series C ·
$85M
B
San Francisco, United States · Biotechnology
Bluejay Therapeutics is a private biopharmaceutical company that is working on developing treatments for…
Series C ·
$182M
B
Basel, Switzerland · Biotechnology
Bioversys AG is a biopharmaceutical company located in Basel that focuses on research and development of new…
Series C ·
$14M
Z
Waltham, United States · Biotechnology
Zenas BioPharma is a company based in Florida, USA that specializes in creating immune-focused treatments for…
Series C ·
$200M
K
Redwood City, United States · Biotechnology
Karius is a biotech company that specializes in providing genomic information on infectious diseases through…
Series C ·
$100M
E
Solana Beach, United States · Biotechnology
Endeavor BioMedicines creates novel therapies that address the root issues of pulmonary fibrosis. Established…
Series C ·
$133M
A
San Francisco, United States · Biotechnology
Asher Bio is a technology company that specializes in CFO Office transformation, profitability, and cost…
Series C ·
$55M
E
Jersey City, United States · Biotechnology
Evergreen Theragnostics is a company established in 2019 that offers radiopharmaceutical development services…
Series C ·
$26M
A
Fremont, United States · Biotechnology
Alamar Biosciences creates tools for identifying and treating cancer and other illnesses as quickly as…
Series C ·
$100M
B
Baltimore, United States · Biotechnology
b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for…
Series C ·
$40M
E
Glasgow, United Kingdom · Biotechnology
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and…
Series C ·
Undisclosed
A
Columbus, United States · Biotechnology
Avation Medical is pioneering new platforms for wearable nerve stimulation systems. They believe empowering…
Series C ·
$22M
L
New York, United States · Biotechnology
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are…
Series C ·
$75M
S
Boston, United States · Biotechnology
SmartLabs creates comprehensive research spaces for businesses, encompassing versatile labs for research and…
Series C ·
$48M
G
Oxford, United Kingdom · Biotechnology
The goal of Genomics plc is to take the lead in revolutionizing healthcare through genomics. They aim to…
Series C ·
$45M
C
San Diego, United States · Biotechnology
Certis Oncology Solutions was established in 2016 with the aim of delivering personalized and precise medical…
Series C ·
$10M
P
Seattle, United States · Biotechnology
Parse Bio is a biotech startup that develops single-cell sequencing kits for researchers. Their technology…
Series C ·
$50M
O
Cambridge, United States · Biotechnology
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation…
Series C ·
$101M
O
Northbrook, United States · Biotechnology
On Target Laboratories is a company that discovers and develops special imaging agents that can be used…
Series C ·
$30M
N
Basel, Switzerland · Biotechnology
Nouscom is a company that develops an immunotherapy platform designed to produce modified viral vector…
Series C ·
$72M
E
Boston, United States · Biotechnology
Elucid, a medical technology company based in Boston, is using advanced AI technology to provide doctors with…
Series C ·
$80M
4
Cham, Switzerland · Biotechnology
4D Lifetec is a biotech firm that focuses on the advancement and promotion of molecular diagnostics screening…
Series C ·
$26M
A
Ghent, Belgium · Biotechnology
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
Series C ·
$101M
F
Flat Medical
Oakland, United States · Biotechnology
Flat Medical creates safety technology solutions for clinical procedures. These solutions are utilized in…
Series C ·
Undisclosed
A
Seattle, United States · Biotechnology
Avalyn Pharma, headquartered in Seattle, Washington, is a biopharma company dedicated to progressing…
Series C ·
$175M
M
Misgav Dov, Israel · Biotechnology
MitrAssist has introduced a new method for treating mitral regurgitation (MR) that is minimally invasive.…
Series C ·
$100M
O
San Clemente, United States · Biotechnology
Osteal Therapeutics, Inc. is a privately held company located in Solana Beach, CA. Founded in 2013, JPS is…
Series C ·
$23M
E
Glasgow, United Kingdom · Biotechnology
ENOUGH, a spin-off company from the University of Strathclyde, was created to advance and market…
Series C ·
$44M
O
San Francisco, United States · Biotechnology
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation,…
Series C ·
$52M
B
Ecublens, Switzerland · Biotechnology
Anytime, Anywhere, Safe Water Novate Technologies SA creates reliable and cutting-edge tools to raise the bar…
Series C ·
$13M
N
Neuralink
Fremont, United States · Biotechnology
Neuralink is a group of extremely skilled individuals. We are revolutionizing the field of brain-machine…
Series C ·
Undisclosed
E
Hayward, United States · Biotechnology
Eikon Therapeutics is a biopharmaceutical company that specializes in creating new technologies for drug…
Series C ·
$106M
O
Boulder, United States · Biotechnology
OnKure is committed to the discovery and development of best-in-class precision medicines that target…
Series C ·
$54M
B
La Jolla, United States · Biotechnology
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat…
Series C ·
$100M
C
San Diego, United States · Biotechnology
Cullgen aims to generate previously non-existent remedies for illnesses that cannot be treated effectively by…
Series C ·
$35M
P
Austin, United States · Biotechnology
Pattern Bioscience, established in 2016, is a private company focused on solving the issue of antibiotic…
Series C ·
$29M
S
Singapore, Singapore · Biotechnology
The objective of SCG Cell Therapy is to utilize the patient's immune system to combat infections and antigens…
Series C ·
$8.1M
R
Cambridge, United States · Biotechnology
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector…
Series C ·
$87M
C
Alameda, United States · Biotechnology
A high performance materials company called Checkerspot develops materials on a molecular level. We are here…
Series C ·
$55M
R
Salt Lake City, United States · Biotechnology
The first biosafety technology firm, R-Zero, is committed to making the shared indoor environments safer,…
Series C ·
$105M
A
Écully, France · Biotechnology
Amolyt Pharma is using its team's proven proficiency in the development of therapeutic peptides to provide…
Series C ·
$139M
S
Menlo Park, United States · Biotechnology
A business called Synthekine is creating modified cytokine therapies for treating diseases. The business…
Series C ·
$100M
B
Menlo Park, United States · Biotechnology
BillionToOne is a precision diagnostics company that uses technology to accurately count DNA molecules at a…
Series C ·
$49M
K
Greenville, United States · Biotechnology
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of…
Series C ·
$18M
A
Halifax, Canada · Biotechnology
Founded in 2012, we are focused on researching, developing, and commercializing breakthrough medical device…
Series C ·
$30M

83 more funded startups

183 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Dec 2022). The full 183-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 183 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Countries with the most funded Series C Biotechnology startups

Where funded Series C Biotechnology startups are headquartered, by the country on the company record.

Where are funded Series C Biotechnology startups located?

Where funded Series C Biotechnology startups are based, by the city on the company record.

Top investors in Series C Biotechnology startups

The investors named most often across funded Series C Biotechnology startups.

Investor
Companies backed
Fidelity
4
Alpha Wave Global
2
Sanofi Ventures
2

Counts companies in this segment that name the firm as a backer. Investor names entered the pipeline in July 2026, so they cover the companies funded since.

About the FundedIQ Series C Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 183 funded Series C Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (2 of 57 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series C Biotechnology startups is dated Sep 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series C Biotechnology startups are there?

FundedIQ tracks 183 funded Series C Biotechnology startups. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series C Biotechnology startups raised?

Series C Biotechnology startups tracked by FundedIQ have raised $5.3B in disclosed capital across 57 funding rounds over the last 24 months, including 30 rounds in the last 12 months. 55 of those 57 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Series C Biotechnology startups?

United States leads with 137 companies, ahead of United Kingdom (13), Switzerland (8) and France (5).

Which cities have the most funded Series C Biotechnology startups?

Cambridge leads with 23 companies, then Boston (11), San Francisco (10) and Waltham (8).

Which investors back the most Series C Biotechnology startups?

Fidelity, Alpha Wave Global and Sanofi Ventures appear most often across funded Series C Biotechnology startups in the FundedIQ dataset. The count is the number of tracked companies naming each firm as a backer, so it reflects the companies on record rather than every deal a firm has ever done.

What is a typical funding round size for Series C Biotechnology startups?

The median disclosed round over the last 24 months is $80M, and the middle half of rounds fall between $36M and $115M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series C Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series C Biotechnology startups is dated Sep 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.